{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T20:41:57Z","timestamp":1792356117867,"version":"4.4.0"},"reference-count":92,"publisher":"Informa UK Limited","issue":"5","license":[{"start":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T00:00:00Z","timestamp":1762128000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"},{"start":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T00:00:00Z","timestamp":1762128000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/doi.org\/10.1080\/policies-text-data-mining"}],"funder":[{"DOI":"10.13039\/100014012","name":"FightMND","doi-asserted-by":"publisher","award":["61138220"],"award-info":[{"award-number":["61138220"]}],"id":[{"id":"10.13039\/100014012","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Neurodegenerative Disease Management"],"published-print":{"date-parts":[[2026,9,3]]},"DOI":"10.1080\/17582024.2025.2573608","type":"journal-article","created":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T11:49:22Z","timestamp":1762170562000},"page":"603-618","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":4,"title":["Guidelines addressing Motor Neurone Disease (MND): a scoping review"],"prefix":"10.1080","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0924-5042","authenticated-orcid":false,"given":"Cindy","family":"Stern","sequence":"first","affiliation":[{"name":"The University of Adelaide","place":["Adelaide, Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7099-929X","authenticated-orcid":false,"given":"Ines","family":"Semendric","sequence":"additional","affiliation":[{"name":"The University of Adelaide","place":["Adelaide, Australia"]},{"name":"The University of Adelaide","place":["Adelaide, Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3542-8130","authenticated-orcid":false,"given":"Nipun","family":"Shrestha","sequence":"additional","affiliation":[{"name":"The University of Adelaide","place":["Adelaide, Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8048-6319","authenticated-orcid":false,"given":"Jay","family":"Beasley-Hall","sequence":"additional","affiliation":[{"name":"The University of Adelaide","place":["Adelaide, Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7246-0485","authenticated-orcid":false,"given":"Sabira","family":"Hasanoff","sequence":"additional","affiliation":[{"name":"The University of Adelaide","place":["Adelaide, Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6897-814X","authenticated-orcid":false,"given":"Timothy","family":"Barker","sequence":"additional","affiliation":[{"name":"The University of Adelaide","place":["Adelaide, Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6604-0609","authenticated-orcid":false,"given":"Danielle","family":"Pollock","sequence":"additional","affiliation":[{"name":"The University of Adelaide","place":["Adelaide, Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0828-1612","authenticated-orcid":false,"given":"Camille","family":"Schubert","sequence":"additional","affiliation":[{"name":"The University of Adelaide","place":["Adelaide, Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9054-9088","authenticated-orcid":false,"given":"Lynne","family":"Giles","sequence":"additional","affiliation":[{"name":"The University of Adelaide","place":["Adelaide, Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steve","family":"Vucic","sequence":"additional","affiliation":[{"name":"The University of Sydney","place":["Sydney, Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7293-4262","authenticated-orcid":false,"given":"Tracy","family":"Merlin","sequence":"additional","affiliation":[{"name":"The University of Adelaide","place":["Adelaide, Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7091-5842","authenticated-orcid":false,"given":"Zachary","family":"Munn","sequence":"additional","affiliation":[{"name":"The University of Adelaide","place":["Adelaide, Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2025,11,3]]},"reference":[{"key":"e_1_3_9_3_1","unstructured":"MND Australia. What is motor neurone disease? MND Australia; [updated 2024 Mar [cited 2025 Jan 29]. Available from: https:\/\/www.mndaustralia.org.au\/mnd-connect\/what-is-mnd\/what-is-motor-neurone-disease-mnd"},{"key":"e_1_3_9_4_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000207474"},{"key":"e_1_3_9_5_1","first-page":"28","volume-title":"Motor neurone disease: assessment and management","author":"National Institute for Health and Care Excellence (NICE)","year":"2019","unstructured":"National Institute for Health and Care Excellence (NICE). Motor neurone disease: assessment and management. London: NICE; 2019. p. 28."},{"key":"e_1_3_9_6_1","unstructured":"Deloitte Access Economics. Economic analysis of motor neurone disease in Australia report for Motor Neurone Disease Australia. Canberra; 2015."},{"key":"e_1_3_9_7_1","doi-asserted-by":"publisher","DOI":"10.31128\/AJGP-07-21-6097"},{"key":"e_1_3_9_8_1","doi-asserted-by":"publisher","DOI":"10.1136\/practneurol-2021-002989"},{"key":"e_1_3_9_9_1","unstructured":"MND Australia. Overview of MND: mND Australia; [updated Jul 21; cited 2025 Jan 29]. Available from: https:\/\/www.mndaustralia.org.au\/mnd-connect\/for-health-professionals-service-providers\/overview-of-mnd-for-health-professionals#:~:text=Average%20survival%20time%20after%20diagnosis of%20progression%20and%20survival%20time"},{"key":"e_1_3_9_10_1","first-page":"33","article-title":"Understanding the experiences of unpaid carers of people living with MND","author":"Motor Neurone Disease Association","year":"2022","unstructured":"Motor Neurone Disease Association. Understanding the experiences of unpaid carers of people living with MND. Final Report. 2022;33. https:\/\/www.mndassociation.org\/sites\/default\/files\/2022-12\/Carers-Report-External-version.pdf","journal-title":"Final Report"},{"key":"e_1_3_9_11_1","doi-asserted-by":"publisher","DOI":"10.1111\/ene.16264"},{"key":"e_1_3_9_12_1","doi-asserted-by":"publisher","DOI":"10.1186\/s42466-023-00251-x"},{"key":"e_1_3_9_13_1","series-title":"MND New Zealand","volume-title":"New Zealand best practice recommendations for the care of people with motor neurone disease","author":"Motor Neurone Disease New Zealand","year":"2022","unstructured":"Motor Neurone Disease New Zealand. New Zealand best practice recommendations for the care of people with motor neurone disease. MND New Zealand: Auckland, New Zealand; 2022."},{"key":"e_1_3_9_14_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e3181bc01a4"},{"key":"e_1_3_9_15_1","doi-asserted-by":"publisher","DOI":"10.1503\/cmaj.191721"},{"key":"e_1_3_9_16_1","unstructured":"FightMND. About FightMND. 2025 [cited 2025 Feb 2]. Available from: https:\/\/fightmnd.org.au\/about\/about-fightmnd\/"},{"key":"e_1_3_9_17_1","unstructured":"Medicine Io. Clinical practice guidelines we can trust. Washington (DC): The National Academies Press; 2011. English. (Graham R Mancher M Wolman DM et al. editors.)."},{"key":"e_1_3_9_18_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12874-018-0611-x"},{"key":"e_1_3_9_19_1","doi-asserted-by":"publisher","DOI":"10.3109\/21678421.2016.1167911"},{"key":"e_1_3_9_20_1","doi-asserted-by":"publisher","DOI":"10.46658\/JBIMES-24-09"},{"key":"e_1_3_9_21_1","doi-asserted-by":"publisher","DOI":"10.7326\/M18-0850"},{"key":"e_1_3_9_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2018.11.030"},{"key":"e_1_3_9_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2024.111494"},{"key":"e_1_3_9_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neurobiolaging.2016.12.013"},{"key":"e_1_3_9_25_1","volume-title":"Clinical practice guidelines we can trust","author":"Institute of Medicine (US) Committee on Standards for Developing Trustworthy Clinical Practice Guidelines","year":"2011","unstructured":"Institute of Medicine (US) Committee on Standards for Developing Trustworthy Clinical Practice Guidelines. Clinical practice guidelines we can trust. Graham R, Mancher M, Miller Wolman D, et al. editors. Washington (DC): National Academies Press (US); 2011."},{"key":"e_1_3_9_26_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n71"},{"key":"e_1_3_9_27_1","doi-asserted-by":"publisher","DOI":"10.1503\/cmaj.090449"},{"key":"e_1_3_9_28_1","doi-asserted-by":"publisher","DOI":"10.11124\/JBIES-22-00123"},{"key":"e_1_3_9_29_1","doi-asserted-by":"publisher","DOI":"10.18071\/isz.74.0079"},{"key":"e_1_3_9_30_1","unstructured":"Dutch Association of Rehabilitation Physicians (VRA). Amyotrofische laterale sclerose \u2013 ALS (guideline for palliative care in amyotrophic lateral sclerosis \u2013 ALS.). 2021;59. https:\/\/palliaweb.nl\/richtlijnen-palliatieve-zorg\/richtlijn\/als"},{"key":"e_1_3_9_31_1","doi-asserted-by":"publisher","DOI":"10.5692\/clinicalneurol.cn-001946"},{"key":"e_1_3_9_32_1","doi-asserted-by":"publisher","DOI":"10.17712\/nsj.2020.3.20200083"},{"key":"e_1_3_9_33_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-1331.2011.03501.x"},{"key":"e_1_3_9_34_1","doi-asserted-by":"publisher","DOI":"10.1055\/a-1303-7449"},{"issue":"12","key":"e_1_3_9_35_1","first-page":"S231","article-title":"Addressing the role of edaravone in the management of amyotrophic lateral sclerosis and gaps in care and access: expert panel recommendations","volume":"27","author":"Barrington CJ","year":"2021","unstructured":"Barrington CJ, Burruano M, Carney C, et al. Addressing the role of edaravone in the management of amyotrophic lateral sclerosis and gaps in care and access: expert panel recommendations. Am J Manag Care. 2021;27(12 Suppl):S231\u2013S237.","journal-title":"Am J Manag Care"},{"issue":"6","key":"e_1_3_9_36_1","first-page":"841","article-title":"Assessing and treating pain in movement disorders, amyotrophic lateral sclerosis, severe acquired brain injury, disorders of consciousness, dementia, oncology and neuroinfectivology. Evidence and recommendations from the Italian consensus conference on pain in neurorehabilitation","volume":"52","author":"Bartolo M","year":"2016","unstructured":"Bartolo M, Chio A, Ferrari S, et al. Assessing and treating pain in movement disorders, amyotrophic lateral sclerosis, severe acquired brain injury, disorders of consciousness, dementia, oncology and neuroinfectivology. Evidence and recommendations from the Italian consensus conference on pain in neurorehabilitation. Eur J Phys Rehabil Med. 2016;52(6):841\u2013854.","journal-title":"Eur J Phys Rehabil Med"},{"key":"e_1_3_9_37_1","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2023.1154579"},{"key":"e_1_3_9_38_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clnu.2017.09.003"},{"key":"e_1_3_9_39_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-1331.2010.03069.x"},{"key":"e_1_3_9_40_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neurol.2023.07.011"},{"key":"e_1_3_9_41_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.nmd.2020.07.008"},{"key":"e_1_3_9_42_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.nmd.2025.105278"},{"key":"e_1_3_9_43_1","doi-asserted-by":"publisher","DOI":"10.4103\/0972-2327.186825"},{"key":"e_1_3_9_44_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-1331.2010.02951.x"},{"key":"e_1_3_9_45_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.nmd.2017.02.014"},{"key":"e_1_3_9_46_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmr.2024.06.006"},{"key":"e_1_3_9_47_1","doi-asserted-by":"publisher","DOI":"10.1002\/ana.27097"},{"key":"e_1_3_9_48_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.chest.2023.03.011"},{"key":"e_1_3_9_49_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinph.2014.05.021"},{"key":"e_1_3_9_50_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinph.2020.02.022"},{"key":"e_1_3_9_51_1","doi-asserted-by":"publisher","DOI":"10.1155\/2011\/139769"},{"key":"e_1_3_9_52_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.nmd.2017.11.005"},{"key":"e_1_3_9_53_1","volume-title":"Guidance on the use of riluzole (Rilutek) for the treatment of motor neurone disease","author":"National Institute for Health and Care Excellence (NICE)","year":"2001","unstructured":"National Institute for Health and Care Excellence (NICE). Guidance on the use of riluzole (Rilutek) for the treatment of motor neurone disease. London: NICE; 2001."},{"key":"e_1_3_9_54_1","first-page":"45","volume-title":"Motor neurone disease: assessment and management","author":"National Institute for Health and Care Excellence (NICE)","year":"2019","unstructured":"National Institute for Health and Care Excellence (NICE). Motor neurone disease: assessment and management. London: NICE; 2019. p. 45."},{"key":"e_1_3_9_55_1","volume-title":"Intramuscular diaphragm stimulation for ventilator-dependent chronic respiratory failure caused by motor neurone disease","author":"National Institute for Health and Care Excellence (NICE)","year":"2017","unstructured":"National Institute for Health and Care Excellence (NICE). Intramuscular diaphragm stimulation for ventilator-dependent chronic respiratory failure caused by motor neurone disease. NICE; 2017."},{"key":"e_1_3_9_56_1","doi-asserted-by":"publisher","DOI":"10.1111\/ene.13728"},{"key":"e_1_3_9_57_1","doi-asserted-by":"publisher","DOI":"10.1080\/21678421.2024.2397517"},{"key":"e_1_3_9_58_1","doi-asserted-by":"publisher","DOI":"10.1080\/21678421.2017.1304558"},{"key":"e_1_3_9_59_1","doi-asserted-by":"publisher","DOI":"10.1080\/21678421.2017.1404109"},{"key":"e_1_3_9_60_1","doi-asserted-by":"publisher","DOI":"10.1002\/mus.26408"},{"key":"e_1_3_9_61_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.nrl.2021.07.008"},{"key":"e_1_3_9_62_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-020-01366-z"},{"key":"e_1_3_9_63_1","doi-asserted-by":"publisher","DOI":"10.1002\/acn3.51895"},{"key":"e_1_3_9_64_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.nmd.2015.09.009"},{"key":"e_1_3_9_65_1","doi-asserted-by":"publisher","DOI":"10.1212\/CPJ.0000000000200310"},{"key":"e_1_3_9_66_1","doi-asserted-by":"publisher","DOI":"10.1212\/CPJ.0000000000200374"},{"key":"e_1_3_9_67_1","doi-asserted-by":"publisher","DOI":"10.3233\/JND-200617"},{"key":"e_1_3_9_68_1","doi-asserted-by":"publisher","DOI":"10.1177\/23743735221077535"},{"issue":"1","key":"e_1_3_9_69_1","first-page":"1","article-title":"Consensus from the Brazilian Academy of Neurology for the diagnosis, genetic counseling, and use of disease-modifying therapies in 5q spinal muscular atrophy [consenso da Academia Brasileira de Neurologia para diagnostico, aconselhamento genetico e uso de terapias modificadoras na atrofia muscular espinhal 5q]","volume":"82","author":"Zanoteli E","year":"2024","unstructured":"Zanoteli E, Araujo A, Becker MM, et al. Consensus from the Brazilian Academy of Neurology for the diagnosis, genetic counseling, and use of disease-modifying therapies in 5q spinal muscular atrophy [consenso da Academia Brasileira de Neurologia para diagnostico, aconselhamento genetico e uso de terapias modificadoras na atrofia muscular espinhal 5q]. Brazilian Academy of Neurology. 2024;82(1):1\u201318.","journal-title":"Brazilian Academy of Neurology"},{"key":"e_1_3_9_70_1","unstructured":"National Institute for Health and Care Excellence. Motor neurone disease: assessment and management United Kingdom. 2016."},{"key":"e_1_3_9_71_1","unstructured":"(VRA). DAoRP. Amyotrofische laterale sclerose \u2013 ALS (guideline for palliative care in amyotrophic lateral sclerosis \u2013 ALS.). 2021;59. https:\/\/palliaweb.nl\/richtlijnen-palliatieve-zorg\/richtlijn\/als"},{"key":"e_1_3_9_72_1","unstructured":"(WHO) WHO. Countries 2025. [cited 2025 Apr 15]. Available from: https:\/\/www.who.int\/countries"},{"key":"e_1_3_9_73_1","unstructured":"MND Australia. MND to receive specialist pathway in the NDIS 2024. [cited 2025 Apr 16]. Available from: https:\/\/www.mndaustralia.org.au\/articles\/mnd-to-receive-specialist-pathway-in-the-ndis"},{"key":"e_1_3_9_74_1","doi-asserted-by":"publisher","DOI":"10.4082\/kjfm.22.0178"},{"key":"e_1_3_9_75_1","article-title":"The evidence for caring for people living with motor neurone disease: a living evidence and gap map protocol","author":"Pollock D","year":"2025","unstructured":"Pollock D, Stern C, Bond M, et al. The evidence for caring for people living with motor neurone disease: a living evidence and gap map protocol. Clinical and Public Health Guidelines Journal. 2025.","journal-title":"Clinical and Public Health Guidelines Journal"},{"key":"e_1_3_9_76_1","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.su7101a1"},{"key":"e_1_3_9_77_1","unstructured":"NHMRC. Guidelines for guidelines handbook: national Health and Medical Research Council available from. Available from: www.nhmrc.gov.au\/guidelinesforguidelines"},{"key":"e_1_3_9_78_1","unstructured":"World Health Organization (WHO). Handbook for guideline development. World Health Organization (WHO); 2014. Available from: https:\/\/iris.who.int\/bitstream\/handle\/10665\/145714\/9789241548960_eng.pdf?sequence=1"},{"key":"e_1_3_9_79_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12910-023-00913-0"},{"key":"e_1_3_9_80_1","doi-asserted-by":"publisher","DOI":"10.1097\/CM9.0000000000003529"},{"key":"e_1_3_9_81_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2022-062158"},{"key":"e_1_3_9_82_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2023.08.017"},{"key":"e_1_3_9_83_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13012-022-01223-6"},{"key":"e_1_3_9_84_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-023-02667-9"},{"key":"e_1_3_9_85_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2021-055428"},{"key":"e_1_3_9_86_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12913-022-08975-3"},{"key":"e_1_3_9_87_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.injury.2022.01.047"},{"key":"e_1_3_9_88_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6601077"},{"key":"e_1_3_9_89_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2022.12.022"},{"key":"e_1_3_9_90_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2022.12.024"},{"key":"e_1_3_9_91_1","unstructured":"World Health Organization. Regional Office for Europe. Strengthening countries\u2019 capacities to adopt and adapt evidence-based guidelines: a handbook for guideline contextualization. World Health Organization. Regional office for Europe. 2023. Available from: https:\/\/iris.who.int\/handle\/10665\/372275"},{"key":"e_1_3_9_92_1","doi-asserted-by":"publisher","DOI":"10.1002\/jrsm.1106"},{"key":"e_1_3_9_93_1","doi-asserted-by":"publisher","DOI":"10.1111\/jebm.12266"},{"key":"e_1_3_9_94_1","first-page":"52","volume-title":"Procedures and requirements for meeting the NHMRC standards for clinical practice guidelines","author":"National Health and Medical Research Council (NHMRC)","year":"2024","unstructured":"National Health and Medical Research Council (NHMRC). Procedures and requirements for meeting the NHMRC standards for clinical practice guidelines. Canberra: National Health and Medical Research Council; 2024. p. 52."}],"container-title":["Neurodegenerative Disease Management"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/17582024.2025.2573608","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.tandfonline.com\/doi\/full-xml\/10.1080\/17582024.2025.2573608","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/17582024.2025.2573608","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T08:45:58Z","timestamp":1789721158000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/17582024.2025.2573608"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,3]]},"references-count":92,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,9,3]]}},"alternative-id":["10.1080\/17582024.2025.2573608"],"URL":"https:\/\/doi.org\/10.1080\/17582024.2025.2573608","relation":{},"ISSN":["1758-2024","1758-2032"],"issn-type":[{"value":"1758-2024","type":"print"},{"value":"1758-2032","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,3]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=inmt20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=inmt20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2025-08-05","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-10-03","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-11-03","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}